首页> 外文期刊>Bioscience Reports >The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in?vitro
【24h】

The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in?vitro

机译:有丝分裂调节剂Hec1通过长期的体外非编码RNA BX647187是前列腺癌的关键调节剂

获取原文
           

摘要

Hec1 (highly expressed in cancer) is a member of a conserved Ndc80 (nuclear division cycle 80) complex that regulates mitotic processes. Its overexpression is seen in various tumours and is associated with cancer progression. However, its expression pattern and role inhuman prostate cancer (PCa) still not clear. The aim of our study is to investigate the expression and functional role of Hec1?in human PCa. Hec1 expression was measured in 10 pairs of PCa cancerous and non-cancerous tissue samples by quantitative real-time (qRT)-PCR. The effects of Hec1 on PCa cells were studied by RNAi approach. Apoptosis and cell cycle were analysed by flow cytometry. Cells viability was evaluated using cell counting Kit-8. Cyclin B1–Cdc2 (cell division cycle 2) activity was measured by ELISA assay. Long non-coding (Lnc)RNAs regulated by Hec1 were gained from bioinformatics analysis. The role of LncRNA BX647187, regulated by Hec1, was finally characterized in PCa cells by siRNA. Our results showed that Hec1 mRNA and protein were significantly overexpressed in Human PCa tissues and several PCa cell lines. Silencing Hec1 markedly suppressed proliferation, promoted apoptosis and induced cell-cycle arrest in G2/M-phase in PCa cells. Through bioinformatics analysis and knockdown Hec1?in PCa cells, we found LncRNA BX647187 was positively regulated by Hec1. We further demonstrated that suppression of BX647187?in PCa cells significantly reduced cell proliferation and promoted apoptosis. Thus, we conclude that Hec1 is consistently overexpressed in human PCa and Hec1 is closely linked with human PCa progression through the meditator LncRNA BX647187. Our studies may contribute to understand the molecular mechanism of PCa pathogenesis and clinical therapy.
机译:Hec1(在癌症中高表达)是保守Ndc80(核分裂循环80)复合物的成员,该复合物调节有丝分裂过程。在多种肿瘤中均可见其过度表达,并与癌症进展有关。但是,其表达模式和在人类前列腺癌(PCa)中的作用仍不清楚。我们研究的目的是研究Hec1?在人PCa中的表达和功能。通过定量实时(qRT)-PCR在10对PCa癌和非癌组织样本中测量了Hec1表达。通过RNAi方法研究了Hec1对PCa细胞的作用。通过流式细胞术分析细胞凋亡和细胞周期。使用细胞计数试剂盒8评估细胞活力。 Cyclin B1-Cdc2(细胞分裂周期2)活性通过ELISA测定。从生物信息学分析中获得了受Hec1调控的长非编码(Lnc)RNA。最终,由Hec1调控的LncRNA BX647187的作用在siRNA中在PCa细胞中得以表征。我们的结果表明,Hec1 mRNA和蛋白在人PCa组织和几种PCa细胞系中明显过表达。沉默Hec1可以显着抑制PCa细胞中G2 / M期的增殖,促进凋亡并诱导细胞周期停滞。通过生物信息学分析和敲低PCa细胞中的Hec1 ?,我们发现LncRNA BX647187受Hec1阳性调控。我们进一步证明了PCa细胞中BX647187?的抑制作用显着降低了细胞增殖并促进了细胞凋亡。因此,我们得出结论,Hec1在人PCa中始终过量表达,而Hec1通过冥想者LncRNA BX647187与人PCa进展密切相关。我们的研究可能有助于理解PCa发病机理和临床治疗的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号